Neurotransmitters in Psychiatry (July)

Date of Issue: 07/01/2006 | Volume: 4 | Number: 7

Issue Links:Learning Objectives | Editorial Information

Teaser to be posted soon.

In This Issue


Antidepressants: Does Mechanism Matter?

Topics: Antidepressants

While it’s certainly interesting to theorize about neurotransmitters and antidepressants, the recent STAR*D findings bring up a difficult topic: Does mechanism matter?

Read More

Dopamine: Getting Reaquainted

Topics: ADHD

Dopamine is the new serotonin: everyone is talking about it. Depending on what authority you read, dopamine is central to schizophrenia, ADHD, depression, sexuality, and cognition.

Read More

"It's Anticholinergic" - What does that mean?

Anticholinergic-speak is endemic in psychiatry. Since it’s unlikely to go away, we invite you to buff up your knowledge of acetylcholine (ACh) and to review the many ways in which it makes an appearance in clinical practice.

Read More
Expert QA

History of Neurotransmitters in Psychiatry

Topics: Neuroscience in Psychiatry

Dr. Barondes, you were a researcher at the NIH during the period when the earliest research on neurotransmitters and antidepressants was conducted. What happened while you were there?

Read More
Tales From History

The Father of Reuptake

Julius Axelrod, who won the Nobel Prize for his work in neuroscience, spent much of his career as a lab tech. Born in 1912 on the Lower East Side of Manhattan, he got most of his education at the tuition-free City College of New York, which he described as a “proletarian Harvard.”

Read More